Rheumatology
Conference Coverage
No Increase in Autoimmune Risk Seen With GLP-1 Receptor Agonists and SGLT2 Inhibitors
Patients with type 2 diabetes prescribed GLP-1 receptor agonists or SGLT2 inhibitors did not have a greater risk of developing autoimmune disease...
News from the FDA/CDC
First Denosumab Biosimilar Approved in Two Different Formulations
Denosumab-bddz was also granted interchangeability status, which allows pharmacists to substitute the biosimilar for the reference product without...
Conference Coverage
Top Spondyloarthritis Studies of 2023 Include Underdiagnosis and Treatment in IBD
Besides the need to screen for spondyloarthritis more often in patients with inflammatory bowel disease, Dr. Eric Ruderman discussed finding the...
From the Journals
How Good are Tools to Screen for Spondyloarthritis in Patients With Psoriasis, Uveitis, IBD?
A comparison of screening tools for SpA in conditions that commonly co-occur with the disease revealed few screening tool options for patients...
From the Journals
Osteoporosis Drug Denosumab May Confer Lower Risk for Diabetes
The lower risk for diabetes associated with continued denosumab use in older adults added new evidence to consider when choosing an osteoporosis...
Latest News
Study Evaluates Factors Driving Fatigue in Patients With Psoriasis, PsA
The study “highlights the importance of a symptom-based approach when treating psoriasis, ” the authors wrote.
Pearl of the Month
Unexpectedly Helpful Effects of Drugs Used For Other Reasons
Instead of negative interactions, some drugs have beneficial effects in areas other than their indicated use.
Latest News
Gout Increases the Risk for a Wide Range of Cardiovascular Diseases
This association was more pronounced in women than in men, and gout amplified the risk for CVD in younger individuals to a greater extent.
News from the FDA/CDC
FDA Approves 10th Humira Biosimilar, With Interchangeability
Adalimumab-ryvk (Simlandi) is the first adalimumab biosimilar in a high-concentration formulation to receive interchangeability status from the...
From the Journals
Autoimmune Disease Risk May Rise Following Cushing Disease Remission After Surgery
The findings suggested the need for closer postsurgical monitoring of patients with a family history of autoimmune disease.
Latest News
‘Deep Phenotyping’ Identifies Abnormalities in ME/CFS
Underlying pathophysiology shows autonomic, immune, and metabolic dysfunction.